Duraclon is a prescription medicine licensed for the treatment of severe pain in people with cancer. It is approved to be used in combination with opiates and is given as a continuous epidural infusion. The medication is a type of alpha-2 adrenergic agonist that works by blocking pain signals from reaching the brain. Potential side effects include dizziness, dry mouth, and confusion.
What Is Duraclon?
Duraclon® (clonidine hydrochloride) is a prescription medication approved to treat severe cancer pain. It is given by continuous epidural infusion (an "epidural") and is approved to be used in combination with opiates (like morphine) for treating severe pain in people with cancer.
(Click Duraclon Uses for more information on what the medication is used for, including possible off-label uses.)
Who Makes This Medication?
Brand-name Duraclon is made by Xanodyne pharmaceuticals, inc.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed April 22, 2009.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed April 22, 2009.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click